Tag Archive | funding

Workshop: How to prepare a Discovery Grant application

Guest speakers Flora Marguerite (Program Officer on the Engineering Team) and Jamie Cousineau (Program Officer  Research Grants – Electrical and Computer Engineering) will lead a discussion of what is new at NSERC and what is needed to prepare a successful Discovery Grant application.

Date: Tuesday, May 7th
Time: 9:00AM – 11:00AM
Click here for Registration (attend in person or online via Adobe Connect)

Funding: Launch of NSERC Alliance Grants

The NSERC Alliance grants: Canada’s Research Partnerships Program has officially launched.

Alliance grants encourage greater collaboration in Canada’s R&D system by providing support for projects that include both generators and users of research results and knowledge. Alliance is designed to be more responsive and flexible for our research community and to accommodate a broader range of partners. It also includes incentives for collaborations with small and medium-sized enterprises and multi-sectoral partnerships, and offers an accelerated means for projects to scale and grow.

Alliance will be launched in a phased approach. On May 21st, Option 1 will be open for applications requesting $150,000 or more annually from NSERC. Option 1 for applications requesting less than $150,000 annually from NSERC, as well as Option 2, will be phased in gradually

Click here for full details and application.

Funding: Banting Research Foundation Discovery Award (March 15, 2019)

This is a one-year grant of up to $25K for innovative health and biomedical research by new investigators (within the first three years of their first academic appointment). Eligibility is limited to those who have not been awarded more than $150K in start-up funding and not awarded more than $50K per year in operating funds.

Deadline: March 15, 2019
Click here for link to full details.

Reminder: CDTRP Research Innovation Grant (13 February 2019)

The primary objective of the CDTRP Research Innovation Grant competition is to support new peer-reviewed pilot research projects that align with CDTRP’s One-Transplant-for-Life vision, which is to fulfill every donor opportunity and turn transplant into a cure. These projects must be new stand-alone studies that align with one (1) of five (5) themes of the CDTRP and should be used to generate preliminary data to support further investigation. The five (5) CDTRP Themes are:

  1. Create a culture of donation
  2. Inform universal practices for donation
  3. Engineer and allocate a better graft
  4. Tailor an optimal immune system for each patient
  5. Restore long-term health

Grant recipients are expected to integrate their proposed study within the CDTRP research structure.

The total value of the competition is $510,000 and each grant is a total of $30,000 CDN each, enough to support 17 grants.

Of the $510,000, we will support grants in the following strategic areas:

  • six (6) grants of $30,000 CDN/each to support new research that addresses the One-Transplant-for-Life vision and aligns with one of the 5 Themes. These will be provided through the CDTRP Research Innovation Grant competition over an 18-month performance period with funding provided by Astellas Pharma Canada, Inc.;
  • two (2) grants of $30,000 CDN/each to support new research related to kidney donation and/or transplantation that addresses the One-Transplant-for-Life vision and aligns with one of the 5 Themes. These will be provided through the CDTRP KFOC Research Innovation Grant competition over an 18-month performance period with funding provided by the Kidney Foundation of Canada
  • one (1) grant of $30,000 CDN to support new research in lung transplantation that addresses the unique needs of the cystic fibrosis community, including: improving long-term health outcomes for cystic fibrosis transplant recipients;  transplant immunology and infection in cystic fibrosis; and addressing post-transplant health and social challenges for those living with cystic fibrosis (e.g. long-term exposure to high doses of anti-rejection medications, mental health, support with respect to social re-integration). This will be provided through the CDTRP CF Canada Research Innovation Grant competition over an 18-month performance period with funding provided by Cystic Fibrosis Canada;
  • two (2) grants of $30,000 CDN/each to support new research related to pediatric transplantation that addresses the One-Transplant-for-Life vision and aligns with one of the 5 Themes. One of these projects must be based in British Columbia and the other must be based in Edmonton, Alberta.  The Edmonton project must also be focused on pediatric heart transplantation.  While not required, we strongly encourage the community to submit one combined application that includes both a Vancouver and Edmonton component that will work together to address issues related to pediatric transplantation. These will be provided through the CDTRP Addison Fund Research Innovation Grant competition and the CDTRP Big Gifts for Little Lives Research Innovation Grant competition respectively over an 18-month performance period;
  • The Alberta Transplant Innovation Fund (ATIF) will provide four (4) additional grants of $30,000 CAD/each to the top ranked Alberta-based researchers through the CDTRP ATIF Research Innovation Grant competition over an 18-month performance period. The ATIF receives funding from the Alberta Ministry of Economic Development and Trade, the University Hospital Foundation, and Astellas Pharma Canada;
  • The UHN-MOT will provide two (2) additional grants of $30,000 CDN/each to the top ranked unfunded UHN researchers through the CDTRP UHN Research Innovation Grant competition over an 18-month performance period.

Each grant will be awarded to the successful applicant(s) via the Primary Applicant’s institution.
Click here for full details and to download an application form.

Application Deadline: 13 February 2019
Notification Date: 7 May 2019
Funding Start Date: 20 May 2019, or upon confirmation of REB approval

Reminder: CDTRP Research Innovation Grant (February 13)

The primary objective of the CDTRP Research Innovation Grant competition is to support new peer-reviewed pilot research projects that align with CDTRP’s One-Transplant-for-Life vision, which is to fulfill every donor opportunity and turn transplant into a cure. These projects must be new stand-alone studies that align with one (1) of five (5) themes of the CDTRP and should be used to generate preliminary data to support further investigation. The five (5) CDTRP Themes are:

  1. Create a culture of donation
  2. Inform universal practices for donation
  3. Engineer and allocate a better graft
  4. Tailor an optimal immune system for each patient
  5. Restore long-term health

Grant recipients are expected to integrate their proposed study within the CDTRP research structure.

The total value of the competition is $510,000 and each grant is a total of $30,000 CDN each, enough to support 17 grants.

Of the $510,000, we will support grants in the following strategic areas:

  • six (6) grants of $30,000 CDN/each to support new research that addresses the One-Transplant-for-Life vision and aligns with one of the 5 Themes. These will be provided through the CDTRP Research Innovation Grant competition over an 18-month performance period with funding provided by Astellas Pharma Canada, Inc.;
  • two (2) grants of $30,000 CDN/each to support new research related to kidney donation and/or transplantation that addresses the One-Transplant-for-Life vision and aligns with one of the 5 Themes. These will be provided through the CDTRP KFOC Research Innovation Grant competition over an 18-month performance period with funding provided by the Kidney Foundation of Canada
  • one (1) grant of $30,000 CDN to support new research in lung transplantation that addresses the unique needs of the cystic fibrosis community, including: improving long-term health outcomes for cystic fibrosis transplant recipients;  transplant immunology and infection in cystic fibrosis; and addressing post-transplant health and social challenges for those living with cystic fibrosis (e.g. long-term exposure to high doses of anti-rejection medications, mental health, support with respect to social re-integration). This will be provided through the CDTRP CF Canada Research Innovation Grant competition over an 18-month performance period with funding provided by Cystic Fibrosis Canada;
  • two (2) grants of $30,000 CDN/each to support new research related to pediatric transplantation that addresses the One-Transplant-for-Life vision and aligns with one of the 5 Themes. One of these projects must be based in British Columbia and the other must be based in Edmonton, Alberta.  The Edmonton project must also be focused on pediatric heart transplantation.  While not required, we strongly encourage the community to submit one combined application that includes both a Vancouver and Edmonton component that will work together to address issues related to pediatric transplantation. These will be provided through the CDTRP Addison Fund Research Innovation Grant competition and the CDTRP Big Gifts for Little Lives Research Innovation Grant competition respectively over an 18-month performance period;
  • The Alberta Transplant Innovation Fund (ATIF) will provide four (4) additional grants of $30,000 CAD/each to the top ranked Alberta-based researchers through the CDTRP ATIF Research Innovation Grant competition over an 18-month performance period. The ATIF receives funding from the Alberta Ministry of Economic Development and Trade, the University Hospital Foundation, and Astellas Pharma Canada;
  • The UHN-MOT will provide two (2) additional grants of $30,000 CDN/each to the top ranked unfunded UHN researchers through the CDTRP UHN Research Innovation Grant competition over an 18-month performance period.

Each grant will be awarded to the successful applicant(s) via the Primary Applicant’s institution.
Click here for full details and to download an application form.

Competition Launch: 15 October 2018
Application Deadline: 13 February 2019
Notification Date: 7 May 2019
Funding Start Date: 20 May 2019, or upon confirmation of REB approval

Funding Opportunity: Banting Research Foundation Discovery Award

This is a one-year grant of up to $25K for innovative health and biomedical research by new investigators (within the first three years of their first academic appointment). Eligibility is limited to those who have not been awarded more than $150K in start-up funding and not awarded more than $50K per year in operating funds.

Eligibility:

To be eligible to apply, you must:

  • be a new investigator at any Canadian university or affiliated research institute who will be within the first three years of the date of first career academic appointment at the application deadline date of March 15, 2019
  • have not been awarded by your institution more than $150,000 in start-up funding (exclusive of support from the Canadian Foundation for Innovation)
  • have not been awarded more than $50,000 per annum in external operating funds at the application deadline date. (An applicant who has been awarded more than $50,000 per annum in external operating funds may submit a request for less than $25,000, such that the total sum of operating funds received from all sources during the funding year, should the application to the Banting Research Foundation be successful, not exceed $75,000.)

Institutional Support:

The application must be accompanied by a letter of nomination from the applicant’s host department or division head that:

  • confirms all eligibility criteria have been met
  • details the operating and the institutional start-up funds available to the applicant
  • confirms the candidate has been provided the space and access to institutional infrastructure necessary to conduct the proposed research
  • details a mentorship plan, including the name of a mentor, who will assist the applicant in launching their career by providing guidance with formulating research proposals, defining career goals and the timelines required to achieve them

A department/division head will be permitted to nominate only one potential applicant during each annual granting cycle.

Funding Payments

The maximum duration of the grant is one year, from July 1 to June 30. Extensions may be considered and must be requested in writing at least 30 days prior to the grant end date. Grants are paid quarterly within the funding year, starting July 1. Grants are paid to the finance office of the sponsoring institution. Grantees may draw on this account as needed.

Acceptable Use of Funding

Funds can be used to purchase equipment and for general operating expenses specified in the budget proposal, including salaries for technicians, postdoctoral fellows and students. Funds may not be used to pay the salary of the applicant, overhead, or travel expenses. Equipment purchased with grant funds is the property of the institution at which the grant is held. Any unexpended funds are to be returned to the Banting Research Foundation.

Ethical and Safety Considerations

Applicants are expected to ensure their proposed research complies with ethics and safety guidelines of their home institution. Human research procedures must comply with the Tri-Council Policy Statement, “Ethical Conduct for Research Involving Humans.” Animal experimental procedures must comply with guidelines of the Canadian Council on Animal Care. Procedures for handling biological and chemical hazards must meet CIHR “Guidelines for the Handling of Recombinant DNA Molecules and Animal Viruses and Cells.”

Deadline: March 15, 2019
Click here for full details and application package.

Funding Opportunity: GlycoNet Alberta Partnership Projects

Background and Description of Opportunity:
The Canadian Glycomics Network (GlycoNet) is a Network of Centres of Excellence that focuses on the role of glycans (carbohydrates) in health. Areas of focus are antimicrobials, chronic diseases (including diabetes & obesity), neurodegenerative diseases, and cancer.

The funding for this request for proposals (RFP) is being provided by Alberta Innovates (AI) and seeks to support Alberta-based projects that will lead to tangible benefits to the Province. This includes intellectual property, start-up companies, processes, products, services, policies and/or clinical practice guidelines that can be developed with Partners and/or Stakeholders. Given the source of funding, only investigators located in the Province of Alberta are eligible to apply for funding through this RFP. Investigators from outside of Alberta can be involved in projects, but must support their own activities through other sources of funding.

A key goal of GlycoNet is to support research projects that are multi-disciplinary and preferably translational. Accordingly, this RFP seeks to fund projects that involve two or more research groups in different disciplines. Proposals that involve an investigator who is primarily funded by one of the Tri-Council agencies (e.g., CIHR) working with others primarily funded by one or both of the other Tri-Council agencies (e.g., NSERC and/or SSHRC) will be viewed most favorably.

Requirements:
Project applications must:

  • Be targeted to the role/use of glycans in reducing the economic burden and/or treatment of infectious
    diseases, chronic diseases, diabetes and obesity, rare genetic diseases, or the development of glycobased
    therapeutic proteins and vaccines
  • Must have multi-disciplinary teams involving researchers as described above
  • Lead to tangible deliverables by the end of the project, leading to disease treatment or diagnosis
    • Deliverables include intellectual property, processes, products, services, policies and/or
      clinical practice guidelines that can be developed with Partners and/or Stakeholders
    • Partner refers to an organization providing cash or in-kind contributions towards a Network
      project or the Network’s activities. A Stakeholder is an end-user organization that
      does not provide a financial contribution
  • Demonstrate a 1:2 financial match with partner funding. For every two dollars requested in the proposal from GlycoNet/AI, at least one dollar in matching must be provided. At least 50% of the matching funds should be cash. Funding from provincial funding sources (excluding Alberta Innovates), industry, foundations and federal funding, including from the Tri-Council (e.g., CIHR, NSERC, SSHRC) and CFI, is eligible for matching. However, NSERC Discovery Grant and CIHR Project Grant and SSHRC Insight Grant are not eligible. Please contact info@glyconet.ca if you have specific questions about matching eligibility. The project budget must clearly show the co-contribution of partner funds in alignment with eligible project expenses. Projects that involve an industrial partner will be viewed most favorably
  • Projects with a higher level of matching funds (e.g., 1:1, Partners:GlycoNet) will be viewed more favorably
  • Provide information on the number and type (i.e., undergraduate, graduate student, PDF, etc.) of Highly Qualified Personnel expected to be trained in each year of the project
  • Demonstrate equity, diversity and inclusion within the project team (including at the NI level) and in its activities
  • List the desired type of professional development training that GlycoNet could provide to HQP, for example, lab rotations, communication and writing skills improvement, etc.

Funding Available:
All projects must be completed within one year (12 months). Projects will be funded up to a maximum of $100,000/year and require 1:2 matching as outlined above. Therefore, the total project budget with GlycoNet funding and matching contributions would be a maximum of $150,000/year. Securing additional matching will allow the project budget to increase above $150,000/year. Projects requesting less than the maximum amount will be considered. We anticipate approving up to seven proposals with a funding start date of April 1, 2019.

Eligibility:
This funding call is only available to investigators working at an academic or research institution in the Province of Alberta. Investigators from outside of Alberta can be involved in projects, but they must support their own activities. Furthermore, based on NCE requirements, this opportunity is open only to individuals who are eligible to hold Tri-Council funds; CIHR, NSERC or SSHRC. Furthermore, GlycoNet requires that all investigators receiving Network funding must have other peer-reviewed support. Such support need not be from the Tri-Council. Questions about project suitability can be directed to the GlycoNet Administrative Office (info@glyconet.ca).

Registration:
Potential applicants must register by email to Karli Stein (kstein@glyconet.ca) by January 7, 2019. Upon registration, applicants will receive detailed instructions for completing the full proposal in the GlycoNet Forum. A complete registration includes the project title, a brief project description, a list of investigators and partners involved in the project, and an anticipated budget request (including matching funds, which do not need to be confirmed at the time of registration).

Proposal Submission & Deadline:
Proposals must be submitted through the GlycoNet Forum by 23:59 (PST) on February 8, 2019. Before review, GlycoNet Management will conduct a review of the proposal to ensure compliance with evaluation criteria. If a proposal is missing critical information, the applicants will be requested to provide the missing information within 48 hours, then re-submit through the GlycoNet Forum. If the proposal is not updated as requested, it will be eliminated from the further review. All proposals will be peer-reviewed by the GlycoNet Research Management Committee and/or GlycoNet Commercialization Committee and externally with final approval by the Board of Directors.

Additional Information:
Questions about this opportunity can be sent to info@glyconet.ca.

Update: CIHR in numbers (2017-2018)

The Canadian Institutes of Health Research (CIHR) is the largest funder of health research in Canada, supporting over 13,000 world-class researchers from all pillars of health research and from all regions of Canada. Click here to review a series of graphs that breakdown CIHR’s investments by theme, funding type, and a selection of similar categories.

Funding Update: Information webinars for 2018 CDTRP Research Innovation Grant Competition

CDTRP invites you invites all interested researchers to an information webinar to learn more about its 2018 Research Innovation Grant Competition. The purpose of this competition is to seed new and innovative peer-reviewed pilot projects in the transplant and donation field that align with CDTRP’s One-Transplant-For-Life vision, which is to fulfill every donor opportunity and turn transplant into a cure.  The deadline for this competition is February 13, 2019.
     To learn more about this competition, please join CDTRP for one of two information webinars, or click here for more information. The dates and times of the information webinars:
December 5, 2018 (12pm PT, 1pm MT, 2pm CT, 3pm ET, 4pm AT)
January 15, 2019 (11am PT, 12pm MT, 1pm CT, 2pm ET, 3pm AT)

Funding Opportunity: CDTRP 2018 Research Innovation Competition

The primary objective of the CDTRP Research Innovation Grant competition is to support new peer-reviewed pilot research projects that align with CDTRP’s One-Transplant-for-Life vision, which is to fulfill every donor opportunity and turn transplant into a cure. These projects must be new stand-alone studies that align with one (1) of five (5) themes of the CDTRP and should be used to generate preliminary data to support further investigation. The five (5) CDTRP Themes are:

  1. Create a culture of donation
  2. Inform universal practices for donation
  3. Engineer and allocate a better graft
  4. Tailor an optimal immune system for each patient
  5. Restore long-term health

Grant recipients are expected to integrate their proposed study within the CDTRP research structure.

The total value of the competition is $510,000 and each grant is a total of $30,000 CDN each, enough to support 17 grants.

Of the $510,000, we will support grants in the following strategic areas:

  • six (6) grants of $30,000 CDN/each to support new research that addresses the One-Transplant-for-Life vision and aligns with one of the 5 Themes. These will be provided through the CDTRP Research Innovation Grant competition over an 18-month performance period with funding provided by Astellas Pharma Canada, Inc.;
  • two (2) grants of $30,000 CDN/each to support new research related to kidney donation and/or transplantation that addresses the One-Transplant-for-Life vision and aligns with one of the 5 Themes. These will be provided through the CDTRP KFOC Research Innovation Grant competition over an 18-month performance period with funding provided by the Kidney Foundation of Canada
  • one (1) grant of $30,000 CDN to support new research in lung transplantation that addresses the unique needs of the cystic fibrosis community, including: improving long-term health outcomes for cystic fibrosis transplant recipients;  transplant immunology and infection in cystic fibrosis; and addressing post-transplant health and social challenges for those living with cystic fibrosis (e.g. long-term exposure to high doses of anti-rejection medications, mental health, support with respect to social re-integration). This will be provided through the CDTRP CF Canada Research Innovation Grant competition over an 18-month performance period with funding provided by Cystic Fibrosis Canada;
  • two (2) grants of $30,000 CDN/each to support new research related to pediatric transplantation that addresses the One-Transplant-for-Life vision and aligns with one of the 5 Themes. One of these projects must be based in British Columbia and the other must be based in Edmonton, Alberta.  The Edmonton project must also be focused on pediatric heart transplantation.  While not required, we strongly encourage the community to submit one combined application that includes both a Vancouver and Edmonton component that will work together to address issues related to pediatric transplantation. These will be provided through the CDTRP Addison Fund Research Innovation Grant competition and the CDTRP Big Gifts for Little Lives Research Innovation Grant competition respectively over an 18-month performance period;
  • The Alberta Transplant Innovation Fund (ATIF) will provide four (4) additional grants of $30,000 CAD/each to the top ranked Alberta-based researchers through the CDTRP ATIF Research Innovation Grant competition over an 18-month performance period. The ATIF receives funding from the Alberta Ministry of Economic Development and Trade, the University Hospital Foundation, and Astellas Pharma Canada;
  • The UHN-MOT will provide two (2) additional grants of $30,000 CDN/each to the top ranked unfunded UHN researchers through the CDTRP UHN Research Innovation Grant competition over an 18-month performance period.

Each grant will be awarded to the successful applicant(s) via the Primary Applicant’s institution.
Click here for full details and to download an application form.

Competition Launch: 15 October 2018
Application Deadline: 13 February 2019
Notification Date: 7 May 2019
Funding Start Date: 20 May 2019, or upon confirmation of REB approval